Atazanavir Apixaban 843

Evotaz label

Clinical Bottom Line
Minimal data to guide interaction: risks likely to outweigh benefits
Drug 1
Drug 2
Clinical Effects

Potential for increased risk of bleeding

Management

Avoid combination, use alternative anticoagulant

Alternative Agents
Dabigatran
Import ID
843